We report four female patients with nodular goiter (in two of the four
due to Hashimoto's thyroidits) and one male patient with frank hypoth
yroidism due to Hashimoto's thyroiditis in whom TSH-suppressive or rep
lacement L-T-4 therapy failed to suppress or, respectively, normalize
serum TSH. As is typical in our country, our patients took L-T-4 15-20
min before a light breakfast, Gastrointestinal or other diseases and
drugs known to interfere with the intestinal absorption of L-T-4 were
not the cause of this failure, The gastrointestinal absorption test of
L-T-4 (1000 mu g) was performed in four patients; in three patients i
t revealed peculiar abnormalities in that (i) the absorption peak was
>70% but occurred at 4 hr vs an average of 2 hr in 12 euthyroid contro
ls (EC) and 3 hr in 10 primary hypothyroid controls (HC); (ii) 50% of
the maximal absorption occurred at 110 min vs 45 min in EC and 50 min
in HC; (iii) the maximal increment in T-4 absorption was between 90 an
d 120 min (+111%) vs between 30 and 60 min in EC (+312%) and HC (+354%
), In sum, only the first part of the absorption curve of T-4 was shif
ted to the right (in three of the four women) and this shift was more
pronounced and extended to the second part of the curve in the fourth
patient; in this last patient absorption peak was 44% at 180 min, Base
d on these results, we obtained full suppression or normalization of T
SH by postponing breakfast for at least 60 min after T-4 ingestion. Th
e precise cause for the ''inertia'' in the early phase of T-4 absorpti
on is not known, but since it was observed in two patients with euthyr
oid nodular goiter, it is not associated with hypothyroidism per se.